SCHEMBL24506592

SCHEMBL24506592

CC(C)(C)c1cnc2cnc(N)cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.38
▸ NOS3 P29474 2/20 0.36
▸ NOS1 P29475 2/20 0.36
▸ NOS2 P35228 2/20 0.36
▸ ALOX5AP P20292 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ FGFR1 P11362 3/20 0.33
▸ SRC P12931 2/20 0.33
▸ GFER P55789 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24506866 0.76 BACE1 (0.42) NOS2ALOX5APNPC1RAB9ABACE1
SCHEMBL24506792 0.75 HTR1D (0.33) —
SCHEMBL4548632 0.75 SCN10A (0.42) ALOX5APNPC1RAB9AGAAMAPT
SCHEMBL25449345 0.74 PDPK1 (0.52) PDPK1NOS3NOS1NOS2ALOX5AP
SCHEMBL12056342 0.74 PDPK1 (0.52) PDPK1NOS3NOS1NOS2ALOX5AP
SCHEMBL24506591 0.74 KDM4E (0.38) NPC1RAB9AGAAMAPTKDM4E
SCHEMBL24506569 0.73 GAA (0.39) PDPK1NOS3NOS1NOS2ALOX5AP
SCHEMBL25450494 0.73 MET (0.36) ALOX5APNPC1RAB9AGAAMAPT
SCHEMBL24506860 0.73 GAA (0.33) ALOX5APNPC1RAB9AGAAMAPT
SCHEMBL13619364 0.72 HPGDS (0.43) NPC1RAB9AMAPTTP53LATS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 PDPK1 1049/4885NOS3 1790/4885NOS1 1223/4885
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 PDPK1 1049/4885NOS3 1790/4885NOS1 1223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback